Please login to the form below

Not currently logged in
Email:
Password:

Budget supports Pharma

The pharmaceutical industry in the UK is set to benefit from proposals announced by Chancellor Alistair Darling in this year's Budget

The pharmaceutical industry in the UK is set to benefit from proposals announced by Chancellor Alistair Darling in this year's Budget.

Under the heading of tax and innovation, Darling's Budget contains a proposal which aims to identify any changes to the current system that will encourage innovative industries such as pharma and increase the attractiveness of the UK as a destination for R&D activities. "Working with representatives across the business community, the government will examine the balance of taxation of innovative activity, including intellectual property," the report says.

Commenting on the proposals within the Budget, Dr Richard Barker, director-general of The Association of the British Pharmaceutical Industry (ABPI), said: "The announcement of this consultation demonstrates the commitment of the UK government to life sciences in Britain and represents an important first achievement for the Office for Life Sciences. It could have significant impact on how companies make their investment decisions."

Following the consultation on tax changes, the government will deliver its assessment prior to publication of the Pre-Budget Report in November 2009. 

22nd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics